ETV6 and acute lymphoblastic leukemia: (9) compared the prognosis of 168 ETV6/RUNX1-positive and 494 ETV6/RUNX1-negative B-ALL cases and showed that 5-year EFS and OS rates were significantly higher in the former than in the latter.